Substance Use Disorder Awareness and Education

These are slides for a webinar which reviewed the basic concepts and skills of Motivational Interviewing (MI) and employed MI skills and tools, to illustrate the practical applicability of these tools in clinical practice for their addiction and other patient populations.

Provides a basic introduction of the concepts of the disease model of addiction and the role of the reward system. Using neuroscience concepts as a foundation, clinical manifestations of the disease of addiction are then discussed in the form of case-based presentations.

Describes substance use in the United States and includes recommendations on how to address substance misuse and related health consequences

Provides communities, clinicians, policymakers, and others with information and tools to incorporate evidence-based practices into their communities or clinical settings

Discusses the importance of language when discussing substance use and reviews ways to improve language used during clinical encounters to improve patient care

Provides an overview of neonatal abstinence syndrome (NAS) and how opiate exposure during pregnancy may affect a newborn.

Provides a list of data sources to assist agencies, nonprofit groups, organizations, community groups, and coalitions with collecting and assessing data on opioid use.

Provides information about the 2018 Arizona Opioid Epidemic Act for pharmacists and prescribers of opioids, including legal obligations.

Provides evidence-based recommendations to protect first responders from exposure to fentanyl.

Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.